Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
Bennett, R.S.; Postnikova, E.N.; Liang, J.; Gross, R.; Mazur, S.; Dixit, S.; Kocher, G.; Yu, S.; Georgia-Clark, S.; Gerhardt, D.; Cai, Y.; Marron, L.; Lukin, V.V.; Holbrook, M.R. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses 2021, 13, 893. https://doi.org/10.3390/v13050893
Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Lukin VV, Holbrook MR. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses. 2021; 13(5):893. https://doi.org/10.3390/v13050893
Chicago/Turabian StyleBennett, Richard S., Elena N. Postnikova, Janie Liang, Robin Gross, Steven Mazur, Saurabh Dixit, Gregory Kocher, Shuiqing Yu, Shalamar Georgia-Clark, Dawn Gerhardt, Yingyun Cai, Lindsay Marron, Vladimir V. Lukin, and Michael R. Holbrook. 2021. "Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples" Viruses 13, no. 5: 893. https://doi.org/10.3390/v13050893


